| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $3.7M | +27.3% |
| SG&A Expense | $4.2M | +2.7% |
| Operating Income | -$7.9M | -12.8% |
| Pre-tax Income | -$7.2M | -16.5% |
| Income Tax | $800 | +0.0% |
| Net Income | -$7.2M | -16.5% |
| EPS (Basic) | -$1.27 | +34.2% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.8M | +980.0% |
| Accounts Receivable | $643K | +137.3% |
| Current Assets | $11.5M | +587.1% |
| Total Assets | $13.5M | +254.8% |
| Current Liabilities | $1.1M | -41.2% |
| Stockholders' Equity | $12.5M | +528.5% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.3M | -49.7% |
| Financing Cash Flow | $17.0M | +2776.7% |